Resonance Energy Transfer Assay with Cleavage Sequence and Spacer
AssigneeBioMadison, Inc.
InventorsRobert D. FISH, Min Dong
Life of this patent
Estimating the term…
Abstract
Methods for the identification of inhibitors of botulinum neurotoxins are described. Cells are provided that are genetically engineered to express peptides that act as a substrate for a botulinum neurotoxin and the provide reporting groups. Spacer sequences between the reporting groups serve to optimize energy transfer between the reporting groups. Characterization of the energy transfer-dependent signal prior to and following exposure to a botulinum neurotoxin in the presence of a candidate inhibitor provides a measure of the effectiveness of the candidate inhibitor.
Claims25
A method of screening for an inhibitor of a botulinum neurotoxin, comprising:
- providing a cell genetically engineered to express a construct comprising donor label and an acceptor label positioned to provide an electronic coupling such that the donor can transfer energy to the acceptor by a dipole-dipole coupling mechanism, and
- a linker disposed between the donor label and the acceptor label, wherein the linker is a peptide sequence comprising (a) a cleavage site peptide comprising a SNARE motif, (b) a first peptide spacer interposed between the donor and the cleavage site peptide, and (c) a second peptide spacer interposed between the acceptor and the cleavage site peptide, wherein the first peptide spacer and the second peptide spacer each comprise three to fifteen amino acids and are selected to both increase the primary structure distance between the donor and the acceptor and reduce the tertiary structure distance between the donor and the acceptor relative to a corresponding construct lacking the first spacer and second spacer, such that the construct is characterized by increased electronic coupling between the donor and the acceptor relative to a corresponding construct lacking the first spacer and second spacer;
- characterizing a first signal from the cell;
- contacting the cell with a botulinum neurotoxin in the presence of a candidate inhibitor;
- and
- following contacting the cell with the botulinum neurotoxin, characterizing a second signal from the cell.
A method of screening for an inhibitor of a botulinum neurotoxin, comprising:
- providing a cell genetically engineered to express a construct comprising donor label and an acceptor label positioned to provide an electronic coupling such that the donor can transfer energy to the acceptor by an electronic hop between the donor label and the acceptor label, and
- a linker disposed between the donor label and the acceptor label, wherein the linker is a flexible peptide sequence comprising (a) a cleavage site peptide comprising a SNARE motif, (b) a first peptide spacer interposed between the donor and the cleavage site peptide, and (c) a second peptide spacer interposed between the acceptor and the cleavage site peptide, wherein the first peptide spacer and the second peptide spacer each comprise three to fifteen amino acids and are selected to both increase the primary structure distance between the donor and the acceptor and reduce the tertiary structure distance between the donor and the acceptor relative to a corresponding construct lacking the first spacer and second spacer, such that the construct is characterized by an increase in the electronic hop between the donor and the acceptor relative to a corresponding construct lacking the first spacer and second spacer;
- characterizing a first signal from the cell;
- contacting the cell with a botulinum neurotoxin in the presence of a candidate inhibitor;
- and
- following contacting the cell with the botulinum neurotoxin, characterizing a second signal from the cell.
Dependencies are inferred from the claim text.